Quick Answer
NewGenIvf Group Ltd reported Stockholders Equity of $26.63 million for fiscal year 2025.
NewGenIvf Group Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $26.63M | +2639.7% |
| 2024 | -$1.05M | -128.1% |
| 2023 | $3.74M | +563.4% |
| 2022 | $563.1K | +161.5% |
| 2021 | -$914.9K | +7.0% |
| 2020 | -$984.1K | — |
- NewGenIvf Group Ltd showed an increase of +2639.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, NewGenIvf Group Ltd’s stockholders equity has grown by 2806.1% (from -$984.1 thousand to $26.63 million).
- The most recent figure is from NewGenIvf Group Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: